- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Products
- View as
134790-39-9
T9 of Gemcitabine
Gemcitabine Intermedia 9
134790-39-9 media est pro Hydrochloride Gemcitabino.
Lege plusMitte InquisitionemGemcitabine Intermedia 9
134790-39-9 media est pro Hydrochloride Gemcitabino.
Gemcitabine T9
T9 of Gemcitabine
Gemcitabine Intermedia 9
Gemcitabina T9 est media pro Hydrochloride Gemcitabine.
Lege plusMitte InquisitionemGemcitabine Intermedia 9
Gemcitabina T9 est media pro Hydrochloride Gemcitabine.
CAS NO.1122-28-7
Formulae hypotheticae: C5H2N4
Pondus hypotheticum: 118.1
CAS NO.1122-28-7 est Synthesis Oligonucleotide, media.
Lege plusMitte InquisitionemPondus hypotheticum: 118.1
CAS NO.1122-28-7 est Synthesis Oligonucleotide, media.
CAS 1122-28-7
Formulae hypotheticae: C5H2N4
Pondus hypotheticum: 118.1
CAS 1122-28-7 est Synthesis Oligonucleotide, media.
Lege plusMitte InquisitionemPondus hypotheticum: 118.1
CAS 1122-28-7 est Synthesis Oligonucleotide, media.
CAS#1122-28-7
Formulae hypotheticae: C5H2N4
Pondus hypotheticum: 118.1
CAS#1122-28-7 est pro Synthesi Oligonucleotide, media.
Lege plusMitte InquisitionemPondus hypotheticum: 118.1
CAS#1122-28-7 est pro Synthesi Oligonucleotide, media.
1122-28-7
Formulae hypotheticae: C5H2N4
Pondus hypotheticum: 118.1
1122-28-7 est pro Synthesi Oligonucleotide, media.
Lege plusMitte InquisitionemPondus hypotheticum: 118.1
1122-28-7 est pro Synthesi Oligonucleotide, media.
